Samira El Zind
Neurology with Special Qualifications in Child Neurology · South Bend, INNPI 1326065285
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,668 of the $7,120 with a category attached, or 65.6%. 22 manufacturers reported payments, led by Livanova USA, Inc. at 28.0% of the total. Reporting peaked in 2019 at $3,620 and has fallen 77.1% since, to $830 in 2025.
Across 134 payments — averaging $53.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Livanova USA, Inc.$2K
- Aquestive Therapeutics, Inc.$1K
- UCB, Inc.$1K
- Jazz Pharmaceuticals Inc.$729
- Catalyst Pharmaceuticals, Inc.$383
- Eisai Inc.$363
- plus $1K from 16 others
What the payments were for
- Consulting fees$1,26018%
- Travel & lodging$1,18317%
- Food & beverage$4,66866%
- Education$90%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Livanova USA, Inc. | 21 | $1,996 |
| Aquestive Therapeutics, Inc. | 2 | $1,389 |
| UCB, Inc. | 33 | $1,249 |
| Jazz Pharmaceuticals Inc. | 14 | $729 |
| Catalyst Pharmaceuticals, Inc. | 15 | $383 |
| Eisai Inc. | 9 | $363 |
| Neurelis, Inc. | 8 | $356 |
| SK Life Science, Inc. | 1 | $120 |
| Sunovion Pharmaceuticals Inc. | 6 | $89 |
| Supernus Pharmaceuticals, Inc. | 5 | $87 |
| Greenwich Biosciences, Inc. | 4 | $82 |
| Ironshore Pharmaceuticals Inc. | 3 | $43 |
| Genentech USA, Inc. | 1 | $41 |
| Rhodes Pharmaceuticals L.p. | 2 | $39 |
| Travere Therapeutics, Inc. | 3 | $25 |
| Zogenix Inc. | 1 | $22 |
| Biocodex, Inc. | 1 | $21 |
| Amgen | 1 | $20 |
| Aesculap, Inc. | 1 | $20 |
| Saol Therapeutics Inc. | 1 | $19 |
| AstraZeneca | 1 | $16 |
| Sanofi | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VNS Therapy$1,498
- SYMPAZAN$1,389
- Epidiolex$478
- Fycompa$373
- VALTOCO$214
- VNS THERAPY SENTIVA MODEL 1000 GENERATOR$133
- Nayzilam$125
- XCOPRI$120
- VNS - Sentiva$113
- Briviact$107
How this compares
$7,120 in reported general payments places this provider in the 75th percentile of 25 neurology with special qualifications in child neurology providers in Indiana.
See all neurology with special qualifications in child neurology providers in Indiana →
Other neurology with special qualifications in child neurology in South Bend
- Atiya KhanFort Wayne$1.2M
- Keith RidelIndianapolis$110K
- Jason SantiagoFort Wayne$60K
- Larry SalbergMerrillville$27K
- Kofi QuistIndianapolis$18K
- Daksha VyasMerrillville$8K
- Kristyn TekulveKokomo$4K
- Bittu Majmudar-ShethIndianapolis$1K
- Lauren JamesIndianapolis$832
- James PappasIndianapolis$780
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.